arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

BIO-RAD LABORATORIES, INC.

BIO
$342.64 ▼ -5.49 (-1.58%) at close
Industrials ·Laboratory Analytical Instruments ·USLaboratory Analytical Instruments
71 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

BIO-RAD LABORATORIES, INC. shows strong fundamentals with top-quartile Profit Margin (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $9.2B
Dividend Yield
Revenue Growth 1.1%
Op. Margin 5.8%
ROIC 0.3%
FCF / Share $2.90
Trailing P/E
Price / Book 1.4x
FCF Yield 0.9%
Debt / Equity 0.18
info Valuation on last close. End-of-day price, Aug 6, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$592.10M
↑ +1.1%
Net Income Profit after all expenses
$-527.10M
↓ -173.2%
Operating Margin Operating profit as % of sales
5.8%
↑ +133.6% 33th
FCF / Share Free cash flow per share
$2.90
↓ -15.2%
Long-Term Debt Long-term obligations
$1.20B
— 0.0%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
65
Returns
68
Financial Health
65
Cash Quality
39

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters